Nuruddin Unchwaniwala

Nuruddin Unchwaniwala has a diverse work experience in the field of virology and molecular biology. Nuruddin started their career in 2008 at Hemogenomics Pvt. Ltd as an Application Specialist, where they set up and maintained nucleic acid testing (NAT) labs and improved data analysis and quality control for blood banks.

In 2009, Nuruddin worked as a Research Assistant at Louisiana State University, focusing on understanding the role of an AT-rich region in the Epstein Barr Virus (EBV) genome.

From 2010 to 2016, Nuruddin served as a Graduate Research Assistant at the University of Wisconsin-Madison. During this time, they conducted research on viral replication and viral-host interactions using microscopy techniques. Nuruddin also completed graduate level courses in molecular biology and virology.

In 2016, Nuruddin joined the Morgridge Institute for Research as a Postdoctoral Research Associate, where they studied Flock House Virus (FHV) and its replication process. Nuruddin also worked as an Assistant Scientist, exploring drug targets to inhibit the replication and spread of positive-strand RNA viruses.

Currently, Nuruddin is employed as a Scientist II and Senior Scientist at Assembly Biosciences, Inc. Their work focuses on developing a cure for chronic Hepatitis B and Hepatitis D infections through the use of small molecule viral entry inhibitors, assembly inhibitors, and immune modulators.

Overall, Nuruddin Unchwaniwala has a strong background in virology research and a commitment to finding novel approaches for viral disease treatment and prevention.

Nuruddin Unchwaniwala began their education in 2003, earning a Bachelor's degree in Microbiology, General from KC College in Mumbai in 2006. They then pursued a Master of Science (MS) in Microbiology, General from the University of Mumbai from 2006 to 2008. Following their master's studies, Nuruddin attended the Louisiana State University Health Sciences Center from 2009 to 2010, focusing on Microbiology, Immunology, and Parasitology. Subsequently, they enrolled in the University of Wisconsin-Madison from 2010 to 2015, where they obtained a PhD in Cancer Biology.